MyFinsight
Home
Blog
About
Cash and cash
equivalents
$59,295K
(-31.26%↓ Y/Y)
Prepaid expenses and
other current assets
$2,362K
(-69.25%↓ Y/Y)
Research and development
incentives receivable
$1,281K
(-71.76%↓ Y/Y)
Restricted cash
$335K
(-78.03%↓ Y/Y)
Total current assets
$63,273K
(-36.99%↓ Y/Y)
Intangible assets, net
$13,045K
(-35.95%↓ Y/Y)
Property and equipment,
net
$3,038K
(-32.70%↓ Y/Y)
Right of use assets,
net
$1,618K
(-51.31%↓ Y/Y)
Other assets
$919K
(-2.65%↓ Y/Y)
Total assets
$81,893K
(-36.79%↓ Y/Y)
Total liabilities and
stockholders equity
$81,893K
(-36.79%↓ Y/Y)
Total stockholders
equity
$57,134K
(-44.25%↓ Y/Y)
Total liabilities
$24,759K
(-8.57%↓ Y/Y)
Total stockholders
equity attributable to...
$57,073K
(-44.25%↓ Y/Y)
Noncontrolling interest
$61K
(-41.35%↓ Y/Y)
Total current
liabilities
$11,423K
(-10.23%↓ Y/Y)
Operating lease liability
- non-current
$8,571K
(-13.88%↓ Y/Y)
Contingent consideration
$3,063K
(20.40%↑ Y/Y)
Other non-current
liabilities
$1,487K
(1.29%↑ Y/Y)
Deferred tax liability,
net
$215K
(-45.01%↓ Y/Y)
Accumulated deficit
-$320,208K
(-15.00%↓ Y/Y)
Accumulated other
comprehensive loss foreign...
-$17,738K
(-37.11%↓ Y/Y)
Additional paid-in capital
$394,932K
(0.32%↑ Y/Y)
Accrued expenses and
other current...
$8,829K
(19.89%↑ Y/Y)
Operating lease liability
- current
$1,724K
(-15.32%↓ Y/Y)
Accounts payable
$535K
(-70.28%↓ Y/Y)
Deferred income
$335K
(-78.03%↓ Y/Y)
Deferred a shares, 1
nominal value as at...
$86K
Ordinary shares,
0.000025 nominal value as...
$1K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
Barinthus Biotherapeutics plc. (BRNS)
Barinthus Biotherapeutics plc. (BRNS)
source: myfinsight.com